Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck CancerRitu Chaudhary, Christine H. Chung, Graydon Moorhead et al.|Clinical Cancer Research|2025Cited by 3
Data from Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck CancerRitu Chaudhary, Christine H. Chung, Graydon Moorhead et al.|Unknown|2026Cited by 0
Figure S3 from PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and ApoptosisSowjanya Thatikonda, Christine H. Chung, Ritu Chaudhary et al.|Unknown|2026Cited by 0
Figure S12 from PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and ApoptosisSowjanya Thatikonda, Christine H. Chung, Ritu Chaudhary et al.|Unknown|2026Cited by 0
Data from PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and ApoptosisSowjanya Thatikonda, Christine H. Chung, Ritu Chaudhary et al.|Unknown|2026Cited by 0